Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function
Status:
Completed
Trial end date:
2020-01-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the pharmacokinetics (PK) of linzagolix in
subjects with varying degrees of impaired renal function compared to matched control subjects
with normal renal function